DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Megace ES (Megestrol Acetate) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Megace ® ES (megestrol acetate) oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).

DOSAGE AND ADMINISTRATION

The recommended adult initial dosage of Megace ® ES (megestrol acetate) oral suspension is 625 mg/day (5 mL/day or one teaspoon daily). Please refer to the table below for correct dosing and administration. Shake container well before using.

PRODUCT DIFFERENCES
  Megace® ES Oral Suspension Megace® and other megestrol acetate oral suspensions
mg/mL 125 mg/mL 40 mg/mL
Recommended Daily Dose 625 mg 800 mg
Daily Volume Intake 5 mL (teaspoon) 20 mL (dosing cup)
Formulation Concentrated formula Regular formula

In clinical trials evaluating different dose schedules, daily doses of 400 and 800 mg/day of megestrol acetate oral suspension (800 mg/20 mL equivalent to 625 mg/5 mL of Megace ® ES formula) were found to be clinically effective.

HOW SUPPLIED

Megace ® ES (megestrol acetate) oral suspension is a concentrated formula available as a milky white, lemon-lime flavored oral suspension containing 125 mg of megestrol acetate per mL.

NDC 49884-949-69 Bottles of 150 mL (5 fl. oz.)
STORAGE

Store Megace ® ES (megestrol acetate) oral suspension between 15º to 25º C (59º to 77º F) and dispense in a tight container. Protect from heat.

SPECIAL HANDLING

Health Hazard Data

There is no threshold limit value established by OSHA, NIOSH, or ACGIH.

Exposure or overdose at levels approaching recommended dosing levels could result in side effects described above (see WARNINGS and ADVERSE REACTIONS sections). Women at risk of pregnancy should avoid such exposure.

Manufactured by:

PAR PHARMACEUTICAL COMPANIES, INC.

Spring Valley, New York 10977

Revised: 05/08 OS939-51-1-03

Megace ® is a registered trademark of Bristol-Myers Squibb Company licensed to Par Pharmaceutical, Inc.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017